Eurofins agrees to buy US analytical services firm Advantar Laboratories

By Gareth Macdonald contact

- Last updated on GMT

Eurofins to buy Advantar Laboratories
Eurofins to buy Advantar Laboratories

Related tags: Biotechnology, Chemistry

Eurofins Scientific has agreed to buy analytical services firm Advantar Laboratories in its latest deal in the pharmaceutical space.

The agreement - financial terms of which were not disclosed – will see San Diego, US-based Advantar’s GLP and cGMP laboratory become part of Eurofins' network. The 50 staff employed at the facility will also join Eurofins.

Advantar provides analytical services to the pharmaceutical industry, but its capabilities in biopharmaceutical analysis is where it stands out according to Neal McCarthy from Fairmount Partners, the Philadelphia-based bank which represented Advantar shareholders.

Advantar is strong at both analytical testing and formulation and also has a small manufacturing operation that could be used to make clinical trial supplies or small scale commercial products​” he said, adding the firm also has “expertise is in large molecule projects, which is less common.”

McCarthy – who brokered the sale of US environmental testing firm Air Toxics to Eurofins in 2012 - said Advantar’s proximity to West Coast industry customers was a big selling point. He also predicted Eurofins would hire additional staff and expand the lab.

The acquisition is the latest in series of laboratory takeovers made by Eurofins, many of which have been pharmaceutical services firms.

For example, last month Eurofins bought Australian QC company ams Laboratories – which provides analytical and cGMP Quality Control (QC) services provider for biopharmaceuticals - just two months after ​buying another QC testing firm – Sinensis Life Science BV​;

In June last year Eurofins announced it would pay $40m (€35m) for a 75% stake in Emory Genetics Laboratory (EGL) – a specialist provider of genetic testing service – in a deal with current owner Emory University's School of Medicine.

A week before that the firm bought French testing services firm Biomnis from Bio Alfras SAS for €220m ($249m) and two weeks after it announced a €150m investment in lab group BioAccess.

And a month before that Eurofins acquired US-based testing services specialist Diatherix Laboratories.

Related news

Related products

show more

Removing Aggregates of an Acidic Monoclonal Antibody

Removing Aggregates of an Acidic Monoclonal Antibody

Bio-Rad Laboratories | 22-Oct-2018 | Technical / White Paper

CHT Ceramic Hydroxyapatite Media/Resins are known as the industry gold standard for
impurity removal during monoclonal antibody (mAb) purification....

Single-Step Influenza and Dengue Virus Purification

Single-Step Influenza and Dengue Virus Purification

Bio-Rad Laboratories | 08-Oct-2018 | Application Note

CHT XT is the newest addition to the CHT family of media. It has been designed for superior physical robustness to ensure it can be used repeatedly over...

Cultivation of 3D Cell Aggregates in Perfusion

Cultivation of 3D Cell Aggregates in Perfusion

Eppendorf for Bioprocess – Solutions that grow with you | 17-Sep-2018 | Application Note

3D cell aggregates are of great interest for applications like disease modeling and manufacturing of stem cell-based products. Read more about the cultivation...

Related suppliers

Follow us

Products

View more

Webinars